Demographics | |
Age (year) | 46.0 (13.7) |
Female patients (%) | 26 (52) |
Weight (kg) | 93.0 (43.6) |
Height (m) | 161.8 (9.6) |
Body Mass Index (BMI) (kg/m2) | 35.8 (15.8) |
Obesity classification (%) | |
Normal (BMI <23.0 kg/m2) | 3 (6) |
Overweight (BMI 23.0-24.9 kg/m2) | 8 (16) |
Obesity grade 1 (BMI 25.0-29.9 kg/m2) | 14 (28) |
Obesity grade 2 (BMI 30.0-39.9 kg/m2) | 9 (18) |
Morbid obesity (BMI >40 kg/m2) | 16 (32) |
Comorbidities (%) | |
Metabolic syndrome | 38 (76) |
Hypertension | 30 (60) |
Hypercholesterolemia | 30 (60) |
Diabetes mellitus and impaired fasting glucose | 27 (54) |
Hypertriglyceridemia | 15 (30) |
Biochemical profile | |
Albumin (g/dL) | 4.3 (0.4) |
Total bilirubin (mg/dL) | 0.91 (0.39) |
Aspartate aminotransferase (AST) (U/L) | 50 (32) |
Alanine aminotransferase (ALT) (U/L) | 71 (45) |
Alkaline phosphatase (ALP) (U/L) | 75 (22) |
Fasting plasma glucose (mg/dL) | 114 (36) |
Hemoglobin Alc (%) | 6.3 (1.2) |
Triglyceride (mg/dL) | 143 (54) |
Total cholesterol (mg/dL) | 197 (38) |
High-density lipoprotein (HDL) (mg/dL) | 43 (10) |
Low-density lipoprotein (LDL) (mg/dL) | 124 (35) |